Background: The kidney and cardiovascular system are closely related to each other during the modulation of the cardiovascular homeostasis. However, the search for new alternatives for the treatment and diagnosis of cardiovascular diseases does not take into account this relationship, so their evaluation results and the advantages offered by their global and integrative analysis are wasted. For example, a variety of receptors that are overexpressed in both pathologies is large enough to allow expansion in the search for new molecular targets and ligands. Nanotechnology offers pharmacological targeting strategies to kidney, heart, and blood vessels for overcoming one of the essential restrictions of traditional cardiovascular therapies the ones related to their unspecific pharmacodynamics distribution in these critical organs.
Recent Findings: Drug or contrast agent nano-targeting for treatment or diagnosis of atherosclerosis, thrombosis, renal cancer or fibrosis, glomerulonephritis, among other renal, cardiac and blood vessels pathologies would allow an increase in their efficacy and a reduction of their side effects. Such effects are possible because, through pharmacological targeting, the drug is mainly found at the desired site.
Review Purpose: In this mini-review, active, passive, and physical targeting strategies of several nanocarriers that have been assessed and proposed for the treatment and diagnosis of different cardiovascular diseases, are being addressed.
[http://dx.doi.org/10.2174/1389450119666180131105822] [PMID: 29384060]
[http://dx.doi.org/10.2174/1389450119666180207092831] [PMID: 29412103]
[http://dx.doi.org/10.1002/wnan.1414] [PMID: 27194461]
[http://dx.doi.org/10.2174/0929866525666180530123441] [PMID: 29848259]
[http://dx.doi.org/10.1016/j.nano.2018.08.002] [PMID: 30171903]
[http://dx.doi.org/10.1016/j.biomaterials.2017.11.047] [PMID: 29216534]
[http://dx.doi.org/10.1016/j.jconrel.2014.10.029] [PMID: 25449809]
[http://dx.doi.org/10.1016/j.biomaterials.2014.06.031] [PMID: 25043570]
[http://dx.doi.org/10.1021/acs.biomac.7b01297] [PMID: 29211954]
[http://dx.doi.org/10.1016/j.biomaterials.2014.04.106] [PMID: 24862442]
[http://dx.doi.org/10.2174/0929867325666181008142831] [PMID: 30295183]
[http://dx.doi.org/10.2174/1389450117666160617120926] [PMID: 27321771]
[http://dx.doi.org/10.1016/j.biomaterials.2014.04.087] [PMID: 24875764]
[http://dx.doi.org/10.1016/j.bios.2017.10.047] [PMID: 29101783]
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09843] [PMID: 29133360]
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09944] [PMID: 29133359]